News

Nemluvio was well tolerated and showed sustained improvements in moderate to severe prurigo nodularis during a 2-year treatment period, according to long-term extension data presented at the ...
Intracorneal hemorrhage presenting clinically as a 2-mm black macule on the radial aspect of the right index finger. The lesion is encircled with black surgical marking pen.
ZUG, Switzerland, June 25, 2025--Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the initiation of two new clinical trials to investigate the efficacy and safety ...
Sanofi and Regeneron's Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin ...
Samsung Foundry to mass produce its bleeding-edge 1.4nm process node in 2029, a full two years later than its planned 2027 timeline.
Ultimate Spider-Man #18 tops the Top Eleven Bleeding Cool Weekly Bestseller List beating out Absoliute Wonder Woman and Absolute Flash ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is one of the 10 Best Value Stocks to Buy According to Billionaires. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi announced that the US ...
Abnormal uterine bleeding: symptoms, causes, and medical and surgical treatments--a patient hand-out.
In Japan, nemolizumab is marketed as Mitchga ® and is approved for the treatment of prurigo nodularis, as well as pruritus associated with atopic dermatitis in pediatric, adolescent, and adult ...
Latest Research and Reviews Coral-like branching of conjunctival intracorneal neoplasia: a 40-day progression Hitoshi Hayashi Hiroshi Eguchi Shizuka Koh Research 04 Jul 2025 Eye P: 1-2 ...